Xiaojie Chen, Xiaojie Chen, Xiaojie Chen, Long-Fei Mao, Long-Fei Mao, Long-Fei Mao, . . . Zigang Dong. (2022). Icotinib derivatives as tyrosine kinase inhibitors with anti-esophageal squamous carcinoma activity. Frontiers Media S.A..
Chicago Style (17th ed.) CitationXiaojie Chen, et al. Icotinib Derivatives as Tyrosine Kinase Inhibitors with Anti-esophageal Squamous Carcinoma Activity. Frontiers Media S.A., 2022.
MLA (9th ed.) CitationXiaojie Chen, et al. Icotinib Derivatives as Tyrosine Kinase Inhibitors with Anti-esophageal Squamous Carcinoma Activity. Frontiers Media S.A., 2022.
Warning: These citations may not always be 100% accurate.